List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 70 studies with search of: Open Studies | "Rhabdomyosarcoma"
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma
Conditions: Neuroblastoma;   Sarcoma;   Rhabdomyosarcoma-Embryonal;   Rhabdomyosarcoma- Alveolar;   Neuroectodermal Tumors, Primitive, Peripheral
Interventions: Drug: Tumor Purged/CD25 Depleted Lymphocytes;   Biological: Tumor Purged/CD25 Depleted Lymphocytes with Tumor Lysate/KLH Pulsed Dendritic Cell Vaccine;   Drug: IL-4;   Device: Miltenyi CliniMACS-System;   Drug: Tumor Lysate/KLH Pulsed Dendritic Cell Vaccine;   Drug: KLH;   Drug: MAB 8H9;   Drug: Endotoxin
2 Recruiting Proton RT for the Treatment of Pediatric Rhabdomyosarcoma
Condition: Rhabdomyosarcoma
Intervention: Radiation: Proton Beam Radiation
3 Not yet recruiting EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in Children
Condition: Rhabdomyosarcoma
Intervention: Drug: doxorubicin, cytoxan
4 Recruiting Trial for Localised High-risk Rhabdomyosarcoma and Rhabdomyosarcoma-like Soft Tissue Sarcoma
Condition: Soft Tissue Sarcoma
Intervention: Drug: trofosfamide, idarubicin, etoposide
5 Recruiting A Vaccine Study for High Risk Cancers
Conditions: Neuroblastoma;   Rhabdomyosarcoma;   Osteogenic Sarcoma
Intervention: Biological: MAGE-A1, MAGE-A3, and NY-ESO-1 Vaccine
6 Recruiting Vincristine, Dactinomycin, and Cyclophosphamide in Treating Patients With Embryonal Rhabdomyosarcoma
Condition: Sarcoma
Interventions: Biological: dactinomycin;   Drug: cyclophosphamide;   Drug: vincristine sulfate
7 Recruiting Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Embryonal Rhabdomyosarcoma
Condition: Sarcoma
Interventions: Biological: dactinomycin;   Drug: cyclophosphamide;   Drug: vincristine sulfate;   Radiation: radiation therapy
8 Recruiting A Five-Tier, Phase 2 Open-Label Study of IMC-A12 Administered as a Single Agent
Conditions: Ewing's Sarcoma /Peripheral Neuroectodermal Tumor (PNET);   Rhabdomyosarcoma;   Leiomyosarcoma;   Adipocytic Sarcoma;   Synovial Sarcoma
Intervention: Biological: IMC-A12
9 Recruiting Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma
Condition: Sarcoma
Interventions: Biological: dactinomycin;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: ifosfamide;   Drug: topotecan hydrochloride;   Drug: vincristine sulfate;   Drug: vinorelbine ditartrate;   Procedure: conventional surgery;   Radiation: radiation therapy
10 Recruiting Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
Condition: Sarcoma
Interventions: Biological: dactinomycin;   Drug: cyclophosphamide;   Drug: vincristine sulfate;   Procedure: conventional surgery;   Radiation: radiation therapy
11 Recruiting Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
Condition: Sarcoma
Interventions: Biological: cixutumumab;   Biological: dactinomycin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: ifosfamide;   Drug: irinotecan hydrochloride;   Drug: temozolomide;   Drug: vincristine sulfate
12 Recruiting Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma
Condition: Sarcoma
Interventions: Biological: filgrastim;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: dexrazoxane hydrochloride;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: ifosfamide;   Drug: irinotecan hydrochloride;   Drug: vincristine sulfate;   Procedure: conventional surgery;   Radiation: radiation therapy
13 Recruiting Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
Condition: Sarcoma
Interventions: Biological: dactinomycin;   Drug: cyclophosphamide;   Drug: irinotecan hydrochloride;   Drug: vincristine sulfate;   Radiation: radiation therapy
14 Not yet recruiting Seneca Valley Virus-001 in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features
Conditions: Adrenocortical Carcinoma;   Gastrointestinal Carcinoid Tumor;   Kidney Cancer;   Neuroblastoma;   Retinoblastoma;   Sarcoma
Interventions: Biological: Seneca Valley virus-001;   Other: laboratory biomarker analysis;   Other: pharmacological study
15 Recruiting Methionine PET/CT Studies In Patients With Cancer
Conditions: Brain Tumors and /or Solid Tumors Including:;   Brain Stem Glioma;   High Grade Glioma (GBM+AA) Ependymoma;   Medulloblastoma;   Craniopharyngioma;   Juvenile Pilocytic Astrocytoma (JPA)+Atypical Teratoid Rhabdoid Tumor (ATRT);   Hodgkin Lymphoma;   Non Hodgkin Lymphoma;   Ewing Sarcoma + Osteosarcoma;   Rhabdomyosarcoma;   Neuroblastoma
Intervention: Drug: Methionine
16 Recruiting Radiation Therapy to Treat Musculoskeletal Tumors
Conditions: Sarcoma, Ewing's;   Rhabdomyosarcoma;   Soft Tissue Sarcoma;   Musculoskeletal Tumors
Intervention: Procedure: Delivery of conformal limited margin radiotherapy
17 Recruiting Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse
Conditions: Rhabdomyosarcomas;   Neoplasms, Connective and Soft Tissue;   Ewing Tumor;   Osteosarcomas;   Neuroblastomas;   Medulloblastomas
Intervention: Drug: Vinorelbine, cyclofosfamide
18 Recruiting ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors
Conditions: Glioblastoma;   Rhabdomyosarcomas;   Neuroblastoma;   Osteosarcoma
Intervention: Drug: Irinotecan (Camptosar), Gefitinib (Iressa)
19 Recruiting Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
Conditions: Chordoma;   Desmoid Tumor;   Sarcoma
Interventions: Genetic: reverse transcriptase-polymerase chain reaction;   Other: biologic sample preservation procedure;   Other: laboratory biomarker analysis
20 Recruiting Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Conditions: Kidney Cancer;   Leukemia;   Lymphoma;   Neurotoxicity;   Sarcoma
Interventions: Dietary Supplement: glutamic acid;   Other: placebo

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services